{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T11:46:12Z","timestamp":1767008772582,"version":"3.41.2"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:00:00Z","timestamp":1594684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2020.01133","type":"journal-article","created":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T10:51:42Z","timestamp":1594723902000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["The Safety of Radiotherapy in the Treatment of Primary Cutaneous B-Cell Lymphoma: A Multidisciplinary Systematic Review"],"prefix":"10.3389","volume":"10","author":[{"given":"Alessandro","family":"Di Stefani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Tagliaferri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Lancellotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Fionda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Fossati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Balducci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Federico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Hohaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"De Simone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Antonietta","family":"Gambacorta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ketty","family":"Peris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.3389\/fonc.2019.01238","article-title":"Biological approaches to aggressive cutaneous B-cell lymphomas","volume":"9","author":"Tadiotto Cicogna","year":"2019","journal-title":"Front Oncol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood."},{"key":"B3","doi-asserted-by":"publisher","first-page":"146","DOI":"10.4103\/ijd.IJD_74_17","article-title":"A literature revision in primary cutaneous B-cell lymphoma","volume":"62","author":"Selva","year":"2017","journal-title":"Indian J Dermatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1002\/ajh.25224","article-title":"Cutaneous B-cell lymphomas: 2019 update on diagnosis, risk stratification, and management","volume":"93","author":"Wilcox","year":"2018","journal-title":"Am J Hematol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1093\/annonc\/mdy133","article-title":"ESMO guidelines committee. primary cutaneous lymphomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Willemze","year":"2018","journal-title":"Ann Oncol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ijrobp.2015.01.008","article-title":"Modern radiation therapy for primary cutaneous lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group","volume":"92","author":"Specht","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B7","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1590\/abd1806-4841.20153638","article-title":"Cutaneous primary B-cell lymphomas: from diagnosis to treatment","volume":"90","author":"Lima","year":"2015","journal-title":"An Bras Dermatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1001\/archderm.143.12.1520","article-title":"Results of radiotherapy in 153 primary cutaneous B-cell lymphomas classified according to the WHO-EORTC classification","volume":"143","author":"Senff","year":"2007","journal-title":"Arch Dermatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1097\/01.cco.0000239879.31463.42","article-title":"Primary cutaneous B-cell lymphoma: classification and treatment","volume":"18","author":"Willemze","year":"2006","journal-title":"Curr Opin Oncol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0167-8140(99)00089-4","article-title":"Radiotherapy in the management of cutaneous B-cell lymphoma. Our experience in 25 cases","volume":"52","author":"Kirova","year":"1999","journal-title":"Radiother Oncol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1182\/blood-2008-04-152850","article-title":"European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas","volume":"112","author":"Senff","year":"2008","journal-title":"Blood."},{"key":"B12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3109\/10428194.2015.1040012","article-title":"Primary cutaneous B-cell lymphoma (non-leg type) has excellent outcomes even after very low dose radiation as single-modality therapy","volume":"57","author":"Akhtari","year":"2016","journal-title":"Leuk Lymphoma."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1007\/s00277-018-3471-x","article-title":"Radiation therapy in indolent primary cutaneous B cell lymphoma: a single institute experience","volume":"97","author":"De Felice","year":"2018","journal-title":"Ann Hematol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S0360-3016(02)04199-8","article-title":"Long-term efficacy, curative potential, and prognostic factors of radiotherapy in primary cutaneous B-cell lymphoma","volume":"55","author":"Eich","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1111\/jdv.14972","article-title":"Outcomes of radiation therapy of indolent cutaneous B-cell lymphomas and literature review","volume":"32","author":"Gauci","year":"2018","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s00066-019-01541-7","article-title":"De-escalated radiotherapy for indolent primary cutaneous B-cell lymphoma","volume":"196","author":"Oertel","year":"2020","journal-title":"Strahlenther Onkol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3109\/10428194.2012.723707","article-title":"Radiotherapy in the management of localized primary cutaneous B-cell lymphoma","volume":"54","author":"Pashtan","year":"2013","journal-title":"Leuk Lymphoma."},{"key":"B18","doi-asserted-by":"publisher","first-page":"394","DOI":"10.5301\/tj.5000606","article-title":"Primary cutaneous non-Hodgkin lymphoma: results of a retrospective analysis in the light of the recent ILROG guidelines","volume":"104","author":"Pedretti","year":"2018","journal-title":"Tumori."},{"key":"B19","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.det.2019.05.004","article-title":"Diagnosis and management of cutaneous B-cell lymphomas","volume":"37","author":"Malachowski","year":"2019","journal-title":"Dermatol Clin."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1200\/JCO.1999.17.8.2471","article-title":"Treatment of multifocal primary cutaneous B-cell lymphoma: a clinical follow-up study of 29 patients","volume":"17","author":"Bekkenk","year":"1999","journal-title":"J Clin Oncol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1159\/000072098","article-title":"Therapy of cutaneous lymphoma\u2013current practice and future developments","volume":"26","author":"Dummer","year":"2003","journal-title":"Onkologie."},{"key":"B22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.0303-6987.2006.00544.x","article-title":"Standard and new treatments in cutaneous B-cell lymphomas","volume":"33","author":"Dreno","year":"2006","journal-title":"J Cutan Pathol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1067\/mjd.2003.154","article-title":"Cutaneous marginal zone B-cell lymphoma: a case accompanied by massive plasmacytoid cells","volume":"48","author":"Kiyohara","year":"2003","journal-title":"J Am Acad Dermatol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/ajh.20019","article-title":"Cutaneous B-cell lymphoma: pathological spectrum and clinical outcome in 51 consecutive patients","volume":"75","author":"Sah","year":"2004","journal-title":"Am J Hematol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1200\/JCO.2004.08.044","article-title":"Primary cutaneous B-cell lymphoma treated with radiotherapy: a comparison of the European Organization for Research and Treatment of Cancer and the WHO classification systems","volume":"22","author":"Smith","year":"2004","journal-title":"J Clin Oncol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jaad.2013.04.047","article-title":"Primary cutaneous marginal zone B-cell lymphoma: response to treatment and disease-free survival in a series of 137 patients","volume":"69","author":"Servitje","year":"2013","journal-title":"J Am Acad Dermatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1365-2559.1993.tb00469.x","article-title":"Cutaneous immunocytomas: a clinicopathologic study of 26 cases","volume":"23","author":"Rijlaarsdam","year":"1993","journal-title":"Histopathology."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/dote.12478","article-title":"Variation in palliative care of esophageal cancer in clinical practice: factors associated with treatment decisions","volume":"30","author":"Opstelten","year":"2017","journal-title":"Dis Esophagus."},{"key":"B29","doi-asserted-by":"publisher","first-page":"CD005048","DOI":"10.1002\/14651858.CD005048.pub4","article-title":"Interventions for dysphagia in oesophageal cancer","volume":"10","author":"Dai","year":"2014","journal-title":"Cochrane Database Syst Rev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/j.ijrobp.2016.03.023","article-title":"Radiation therapy for primary cutaneous anaplastic large cell lymphoma: an international Lymphoma Radiation Oncology Group multi institutional experience","volume":"95","author":"Million","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B31","doi-asserted-by":"publisher","first-page":"S110","DOI":"10.1016\/j.brachy.2014.02.405","article-title":"Dose fidelity and conformality for high- dose-rate surface applicator brachytherapy for cutaneous lymphoma lesions of the hand and feet","volume":"13","author":"Devlin","year":"2014","journal-title":"Brachytherapy."},{"key":"B32","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1016\/j.brachy.2014.02.272","article-title":"A HDR method for the treatment of full face cutaneous T-cell lymphoma","volume":"13","author":"O'Farrell","year":"2014","journal-title":"Brachytherapy."},{"key":"B33","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/0360-3016(94)00485-4","article-title":"High dose rate microselectron molds in the treatment of skin tumors","volume":"31","author":"Svoboda","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B34","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1440-1673.1997.tb00462.x","article-title":"Extensive basal cell carcinoma treated with the mould radiotherapy technique","volume":"41","author":"Leung","year":"1997","journal-title":"Australas Radiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/S0190-9622(98)70593-6","article-title":"High-dose-rate brachytherapy with a custom surface mold to treat recurrent squamous cell carcinomas of the forearm","volume":"38","author":"Rudoltz","year":"1998","journal-title":"J Am Acad Dermatol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.brachy.2008.04.004","article-title":"High-dose-rate brachytherapy in a large squamous cell carcinoma of the hand","volume":"7","author":"Fabrini","year":"2008","journal-title":"Brachytherapy."},{"key":"B37","doi-asserted-by":"publisher","first-page":"242","DOI":"10.5114\/jcb.2017.66773","article-title":"Clinical outcomes with high-dose-rate surface mould brachytherapy for intra-oral and skin malignancies involving head and neck region","volume":"9","author":"Budrukkar","year":"2017","journal-title":"J Contemp Brachytherapy."},{"key":"B38","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0360-3016(99)00547-7","article-title":"Treatment of skin carcinomas of the face by high-dose-rate brachytherapy and custom-made surface molds","volume":"47","author":"Guix","year":"2000","journal-title":"In J Radiat Oncol Biol Phys."},{"key":"B39","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.brachy.2010.08.005","article-title":"Treatment of facial cutaneous carcinoma with high-dose-rate contact brachytherapy with customized molds","volume":"10","author":"Maro\u00f1as","year":"2011","journal-title":"Brachytherapy."},{"key":"B40","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.prro.2013.12.003","article-title":"Surface mold brachytherapy for nonmelanoma skin cancer: Canadian patterns of practice","volume":"4","author":"Rose","year":"2014","journal-title":"Pract Radiat Oncol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1007\/s12094-009-0439-2","article-title":"High-dose-rate (HDR) plesiotherapy with custom-made moulds for the treatment of non-melanoma skin cancer","volume":"11","author":"Montero","year":"2009","journal-title":"Clin Trans Oncol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"363","DOI":"10.4103\/0019-5154.74547","article-title":"Plesiotherapy for non-melanoma skin cancer: innovating to overcome!","volume":"55","author":"Ray","year":"2010","journal-title":"Indian J Dermatol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ejso.2011.12.001","article-title":"Role of comorbidities in locally advanced cervical cancer patients administered preoperative chemoradiation: impact on outcome and treatment-related complications","volume":"38","author":"Ferrandina","year":"2012","journal-title":"Eur J Surg Oncol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ejca.2019.06.003","article-title":"Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines","volume":"118","author":"Peris","year":"2019","journal-title":"Eur J Cancer."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.ejso.2013.12.024","article-title":"Hospital of diagnosis and probability to receive a curative treatment for oesophageal cancer","volume":"40","author":"Ko\u00ebter","year":"2014","journal-title":"Eur J Surg Oncol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.radonc.2018.01.013","article-title":"GEC-ESTRO ACROP recommendations in skin brachytherapy","volume":"126","author":"Guinot","year":"2018","journal-title":"Radiother Oncol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.jgo.2018.09.009","article-title":"The role of personalized Interventional Radiotherapy (brachytherapy) in the management of older patients with non-melanoma skin cancer","volume":"10","author":"Lancellotta","year":"2019","journal-title":"J Geriatr Oncol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2178469","DOI":"10.1155\/2018\/2178469","article-title":"Age is not a limiting factor in interventional radiotherapy (brachytherapy) for patients with localized cancer","volume":"2018","author":"Lancellotta","year":"2018","journal-title":"Biomed Res Int."},{"key":"B49","doi-asserted-by":"publisher","first-page":"497","DOI":"10.5114\/jcb.2017.72603","article-title":"Is an Interventional Oncology Center an advantage in the service of cancer patients or in the education?","volume":"9","author":"Kov\u00e1cs","year":"2017","journal-title":"J Contemp Brachytherapy."},{"key":"B50","doi-asserted-by":"publisher","first-page":"260","DOI":"10.5114\/jcb.2018.76982","article-title":"ENT COBRA ONTOLOGY: the covariates classification system proposed by the Head & Neck and Skin GEC-ESTRO Working Group for interdisciplinary standardized data collection in head and neck patient cohorts treated with interventional radiotherapy (brachytherapy)","volume":"10","author":"Tagliaferri","year":"2018","journal-title":"J Contemp Brachytherapy."},{"key":"B51","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ejim.2018.02.012","article-title":"A new standardized data collection system for interdisciplinary thyroid cancer management: thyroid COBRA","volume":"53","author":"Tagliaferri","year":"2018","journal-title":"Eur J Intern Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"540","DOI":"10.5114\/jcb.2017.71795","article-title":"Nomogram for predicting radiation maculopathy in patients treated with Ruthenium-106 plaque brachytherapy for uveal melanoma","volume":"9","author":"Tagliaferri","year":"2017","journal-title":"J Contemp Brachytherapy."},{"key":"B53","doi-asserted-by":"publisher","first-page":"336","DOI":"10.5114\/jcb.2016.61958","article-title":"ENT COBRA (Consortium for Brachytherapy Data Analysis): interdisciplinary standardized data collection system for head and neck patients treated with interventional radiotherapy (brachytherapy)","volume":"8","author":"Tagliaferri","year":"2016","journal-title":"J Contemp Brachytherapy."},{"key":"B54","doi-asserted-by":"publisher","first-page":"497","DOI":"10.5114\/jcb.2015.56465","article-title":"Brachytherapy in non melanoma skin cancer of eyelid: a systematic review","volume":"7","author":"Frakulli","year":"2015","journal-title":"J Contemp Brachytherapy."},{"key":"B55","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1080\/09546634.2017.1341617","article-title":"Review: the reemergence of brachytherapy as treatment for non-melanoma skin cancer","volume":"29","author":"Ota","year":"2018","journal-title":"J Dermatolog Treat."},{"key":"B56","doi-asserted-by":"publisher","first-page":"497","DOI":"10.5114\/jcb.2015.56465","article-title":"Brachytherapy in non melanoma skin cancer of eyelid: a systematic review","volume":"7","author":"Frakulli","year":"2015","journal-title":"J Contemp Brachytherapy."}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.01133\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T10:51:45Z","timestamp":1594723905000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.01133\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,14]]},"references-count":56,"alternative-id":["10.3389\/fonc.2020.01133"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.01133","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2020,7,14]]},"article-number":"1133"}}